New ETFs Could Benefit From Favorable Biotech Seasonality

In recent years, there have been many bad times in which to be long biotechnology stocks and exchange traded funds, but with some marquee industry conferences imminent, the biotech industry is in the midst of one of its most potent seasonal periods. December is the second-best month of the year for...